Related Experiment Videos
Myocardial imaging with Tc-99m teboroxime: technique and initial results
A S Iskandrian1, J Heo, T Nguyen
1Philadelphia Heart Institute, Presbyterian Medical Center of Philadelphia, PA 19104.
American Heart Journal
|March 1, 1991
Summary
Technetium-99m teboroxime myocardial imaging is a feasible alternative to thallium-201 for assessing heart perfusion. Optimized SPECT and planar imaging protocols enhance image quality and patient convenience.
Area of Science:
- Nuclear Medicine
- Cardiovascular Imaging
- Radiopharmaceutical Research
Background:
- Thallium-201 (Tl-201) is a standard for myocardial perfusion imaging.
- Tc-99m teboroxime offers advantages in imaging characteristics.
- Evaluating Tc-99m teboroxime against Tl-201 is crucial for clinical adoption.
Purpose of the Study:
- To assess the feasibility and diagnostic accuracy of Tc-99m teboroxime myocardial imaging.
- To compare Tc-99m teboroxime imaging results with Tl-201.
- To optimize imaging protocols for Tc-99m teboroxime.
Main Methods:
- Tc-99m teboroxime imaging (SPECT and planar) in 22 patients.
- Comparison with Tl-201 imaging.
- Protocol optimization including acquisition time and filters for SPECT, and patient position for planar imaging.
Main Results:
- High agreement (89%) between Tc-99m teboroxime and Tl-201 in identifying perfusion patterns.
- Tc-99m teboroxime myocardial imaging is feasible at rest and during exercise.
- Optimized SPECT (10 sec/frame, Butterworth filter) and upright planar imaging improved quality.
Conclusions:
- Tc-99m teboroxime is a viable alternative for myocardial perfusion imaging.
- Optimized SPECT and planar imaging protocols enhance image quality.
- The technique is convenient for patients and comparable to Tl-201.